Chief Legal Officer Sullivan sold $586K worth of DFTX shares at $45.03, reducing his directly held stake by 3.9% while the stock traded just 4.2% below its 90-day high. This sale follows a pattern of insider selling without offsetting buying activity, though it represents a relatively small portion of his overall position.

Where it could go — Analyst mean target unavailable; broad universe shows 41.7% of similar setups yield positive 90d returns.

Chief Commercial Officer Wiley Matthew T. sold $129K worth of shares, reducing his direct holdings by 1.6% while the stock trades just 4% below its 90-day high. This first insider transaction after a significant price run-up suggests potential profit-taking, though the small size makes it more notable than alarming.

Where it could go — Analyst mean target unavailable; bear case if stock breaks below $40 support level.

Chief Medical Officer Karlin Daniel sold $452K in DFTX shares, reducing his direct stake by 2.0% at a price 4% below the 90-day high. This sale is routine diversification from a long-tenured insider, not a high-conviction bearish signal, as it follows a 163% surge from the stock's recent low and occurs amid a STRONG BUY analyst consensus.

Where it could go — Analyst mean target not provided; bear case if stock breaks below the 90-day low of $17.13.

CEO Barrow Robert sold $1.3M of DFTX at $45.03, reducing his directly held stake by 2.6% at a price just 4.2% below the 90-day high. This sale follows a prior $451K sell three months prior and occurs despite a STRONG BUY consensus from 21 analysts, suggesting potential insider divergence from bullish sentiment. Bear: breaks $21.69 support; Bull: holds above $45 and confirms analyst optimism through earnings on July 29.

Where it could go — Broad base rate 41.7% positive at 90d; bear breaks $21.69, bull holds $45.

CFO Brandi Roberts sold $136K of DFTX at $45.03, reducing her direct stake by 1.4% after the stock rallied 162.9% from its 90d low. This first-ever sale by a long-tenured executive near the 90d high, despite a STRONG BUY consensus, signals potential profit-taking at a key resistance level.

Where it could go — Analyst mean target not provided; broad universe shows 41.7% of similar setups positive at 90d; watch $47.01 as breakout level, $21.69 as key support.